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ABSTRACT
Extension of a Bayesian Method for Viral Genome Re-Sequencing
to Multi-Dimensional Parameters

Sarah Fleischer

Next Generation Sequencing (NGS) refers to all sequencing methods post Sanger Sequencing.
Sequencing By Synthesis is the most well-known method, however it’s inaccessible price is
difficult for some. Thus, a different method also exists, re-sequencing– which relies on a
reference genome to check the validity of each base call.
The standard for determining the validity of a base call is a one parameter quality score.
But, previously a two-parameter Bayesian method was successfully used for re-sequencing
the viral genome. However, a quality parameter was previously not used in the construction
of the cumulative density function for the likelihood. This paper explores the implications
of adding a third parameter to the previously successful method.
It was found that there is no statistical significance between the two and three parameter
methods. Furthermore, it takes significantly longer to process the three-parameter method.
Hence, it is recommended to proceed with future utilization of this re-sequencing technique
with the two-parameter method.
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Chapter 1
Introduction
1.1

SARS-CoV-2

Beginning in March 2020, the SARS-CoV-2 (COVID) Virus was declared a global pandemic.
Since then, there have been over 480 Million cases world wide. The nature of this RNA virus
has resulted in a multitude of different genomes, as it has mutated quite rapidly over its
existence. There have been over 1 million published sequences of the virus since the original
publication of the sequence. Thus, in a virus that is just about 30,000 bases, there are high
levels of variation. Therefore, it has become vital to learn how the changes occur over time.
One method that has been employed has been contact tracing through phone calls. However,
phone-call contact tracing is prone to human error and is reliant consistent cooperation from
the public.
Sequencing allows for the ability to track the spread of mutations and is a reliable way
of characterizing variants. Furthermore, sequencing allows for not just the person based
tracking, that is has been heavily prevalent throughout the most recent pandemic, but also
for the specific regions of genetic variability to be tracked. That way it is possible to not
only understand how the virus mutates overtime, but also allows for a possible predictability.
Also, as the sequence slowly evolves to new, slightly different, but also consistent sequences,
the new primers for the polymerase chain reaction (PCR) are easy to reproduce as the
sequence is constantly understood through this method of re-sequencing. Re-sequencing
1

allows for one to compare other sequences and see how they mutate overtime. It can be
thought of a a way to compare to a snap-shot in time. Then, you can observe the sections
of most mutation, as well as novel areas for specific samples to further study. This method
is particularly beneficial in SARS-CoV-2, as well as other quickly mutating viruses. At the
point of writing this paper there have been five notable variants (Alpha through Omicron).

1.2

Biological Background

The basic DNA structure is a double helix consisting of two strands, called Sense and AntiSense relating to the direction of transcription1 . Each strand consists of a (long) sequence of
the four bases (nucleotide): adenine [A] or thymine [T], cytosine [C], guanine [G]. Adenine
and thymine are complementary and cytosine and guanine are complementary. Thus, if
cytosine is on the Sense strand, in a complementing location on the Anti-Sense strand there
is a guanine. Therefore, the Sense and Anti-Sense strand allow for corresponding, duplicated
information for each read.
At least one strand of DNA with help from RNA constructs the genetic material for
every living organism. DNA can be found in the capsid of viruses or in the nucleus and
Mitochondria of most cells, unicellular and mutlticellular alike. The primary function of
DNA is template for the structure and assembly of an organism at all levels of biological
organization from the cell to organs to the entire organism. The four bases act as puzzle
pieces in a long2 strand, often referred to as ”the genome”. Sequencing is the process of
reading out the puzzle pieces in the the strand in question. This is the starting point of
many, if not most applications of gene technology. Whole-genome sequencing (WGS) is a
relatively recent advancement in biotechnology that combines biochemical techniques with
high-throughput computing.
One critical lab techniques involving DNA or RNA is Polymerase Chain Reaction (PCR).
1
By convention, the two ends of the double stranded DNA are referred to as 50 and 30 . The Sense strand
is oriented from 50 to 30 and the complementing Anti-Sense strand is oriented from 30 to 50 . Transcription
is the process of creating a copy of a strand by an enzyme called DNA polymerase that proceeds along the
strand in the 50 to 30 direction.
2
The COVID genome has ≈ 3 · 104 bases and the human genome has ≈ 3.2 · 109 base pairs
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Invented by Dr. Kary Mullis, the process has four basic steps. Once the DNA is isolated
and combined with the appropriate master Mix (containing essential buffers and chemicals
for PCR) and a primer that fluorescently labels the desired strand, the samples are loaded
into a thermal cycler. A thermal cycler, as it sounds, is a programmable machine that
rotates through a set sequence of temperatures. The thermal cycler goes through four main
temperatures that allow for the DNA to initialize, denature, anneal, and elongate. The
initializing step occurs only once, and brings all of the samples to one starting temperature.
Denaturing breaks the hydrogen bonds between base pairs, annealing binds the primers
to the denatured DNA, and elongation creates creates a complementing strand of DNA.
Thus, now it is possible to repeat the process as there are once again a sequence of DNA to
denature. Once complete, the desired section of DNA is amplified and is able to be used in
various analyses.

1.3

Aspects of Sequencing Technology

We will focus on an emerging technology calls next generation sequencing (NGS). ”Next
generation” refers to technologies that emerged after Sanger Sequencing. It is useful to
understand Sanger Sequencing before discussing what came after it.

1.3.1

Sanger Sequencing

Sanger sequencing, created by Frederick Sanger in 1977, was a revolutionary concept at the
time and was the standard sequencing method until the advent of NGS technologies.
Originally, Sanger sequencing relied on fluorescently labeled molecules called dideoxynucleotides (ddNTP: ddATP, ddTTP, ddCTP, ddGTP) and non-fluorescently labeled deoxynucleotides (dNTP: dATP, dTTP, dCTP, dGTP). The ddNTPs are terminating molecules.
Thus, when used during PCR, the result is amplified strands of the same sequence at various
lengths with the final base being fluorescently labeled. [1]. The sample that is sequenced is
split into four different reactions in which one ddNTP is added with supplementary dNTPs
to allow for all of the bases to have pairs. The result is four separate PCR reactions, where

3

each respective reaction has just one ddNTP with the three remaining bases being dNTPs
(i.e. one PCR would have ddATP, dCTP, dGTP, and dTTP). Each reaction is then
loaded into an agarose gel for gel electrophoresis [1]. As seen in figure 1, distinct
bars are visualized- each representing a specific sequence that was previously amplified.
The location of the bar is determined by
the molecular weight of the read, thus, the
Figure 1: PCR example.
fewer bases in the sequence, the lighter the
sequence, and the further the sequence travels in the gel. Each bar that would show up would indicate a specific location on the strand
of DNA with respect to the column for guanine, cytosine, arginine, and thymine The order
then would be manually recorded. This process was tedious and time-consuming, however
the technology to process that type of information was not yet discovered.
This Sanger method eventually evolved to the more advanced Sanger method that is
used today, when Sanger sequencing is utilized. This involves a capillary tube and a laser
detector. The samples are prepared in a similar way, except instead of loading the samples
into a gel, the samples are loaded into a capillary where a laser is shone through and detects
the frequency of the specific fluorescent label and records that data into a computer. The
Human Genome project began the sequencing the first human genome in 2001 using the
Sanger capillary method and this project was not completed until 2004 [2]. One of the
challenges was that 1.1% of a typical human genome is exons, 24% is introns and 75%
is non-coding DNA [3] . However, non-coding DNA is just as important as coding DNA
and created a large undertaking for such a slow process like Sanger Sequencing. Though
the capillary method is a quicker and less tedious of a process then traditional gel Sanger
Sequencing, it is still much slower than desired.

1.3.2

Next Generation Sequencing

Next Generation Sequencing (NGS) is also referred to as Second Generation Sequencing.
The method of NGS is simply a less expensive and higher-throughput type of sequencing,
4

when compared to Sanger Sequencing NGS allows for sequencing the entire human genome
in less than $1000 and in about a day [4]. This is a huge advantage and allows sequencing to
be able to be accessible to the general population. However, because NGS is so successful,
more research is necessary to fully understand the bounds of what NGS can do and the most
effective ways to use the technology. Of the numerous types of NGS I will outline outline
three of the most commonly used: Sequencing by Synthesis, Sequencing by ligation, and Ion
Semiconductor Sequencing.

Sequencing by Synthesis
Sequencing by Synthesis (SBS) is a quicker and more amplified version of Sanger Sequencing.
This method was originally published by Bently and Balasubramanim [5] along with many
colleagues in 2008 with Solexa that is now owned by Illumina Inc. [5]. The mechanism
is typically split into four main steps: library preparation, cluster generation, sequencing,
and data analysis. The library preparation is produced with randomly cutting and combining DNA fragments with oligonucleotides and are then amplified with primers [5]. The
oligonucleotide is secured to the flow-cell and the strand is completed with a complementary
strand[5]. Then the original strand is denatured and reattached at a new oligonucleotide and
the process of annealing to the flow cell, creating a complementary strand and denaturing
is replicated in order to grow the clusters [5]. This leads to the cluster generation step with
bridge amplification [5]. The strands annealed to the surface now are complemented with
strands that tag each nucleotide made out of ddNTPs, similar to Sanger Sequencing [5].
The fragment then bridges over and anneals the opposite end oligonucleotide to the flow-cell
[5]. The 3’ end is denatured and this process begins again but in the opposite direction so
that all of the bases are properly tagged [5]. To begin the sequencing process, fluorescent
dye that reacts with each tag uniquely to create a unique wave length per base is added
into the flow-cell [5]. A laser that interacts with fluorescent imaging is shown through the
flow-cell and the computer algorithm processes the information into a read and complete
data analysis [5] . The result is a sequenced strand of DNA that has been compared to all
of the other amplified strands to ensure accuracy.

5

Alternatives to SBS
Sequencing by Ligation Sequencing by Ligation technologies are mostly run by ThermoFisher Scientific—previously known as Life Technologies. This method ligates the ends
of DNA fragments in order to mark either end. Then the fragments are amplified with PCR
and attached to a bead [6]. Because of the ligations, the fragmented strands stay separate
and the exact size of the ligated ends is known to make the sequencing process more reliable.
The beads are sequenced by being filtered through an analyzer algorithm and the data is
recorded [6]. The data is compared so that small Misreads can be filtered out with each
repeat fragment from the amplification and the result is sequenced strand of DNA [6].

Ion Semiconductor Sequencing Ion Semiconductor Sequencing is also known as Ion
Torrent Sequencing. Because this type of sequencing works with a pH reader instead of a
wave length detector, there is no need for fluorescently labeled tags, therefore, the sequence
fragments are washed with just dNTPs as opposed to ddNTPs. Ion semiconductor sequencing
works through the properties of the charges on the respective sequences [7] . There are
multiple wash flows through this cycle to create a more distinct change in the pH to make
the pH detector more accurate when it is time for sequencing. The fragments are loaded
onto a chip and is proceeded to be processed similarly to a computer chip. Each section is
sensed similarly to a pixel and is processed in a Boolean logic manner. For example, the
sensor could be sensing for an Adenine and then the algorithm will look for that specific pH
and then if it is not Adenine, then it will look for Guanine and so on. The processor will go
through this process for every location on the chip, until the sequence is fully sequencing.
Because this technology uses a pH reader instead of a fluorescent reader, it is the only current
technology that is reading the original base pair during the processing stage. However, there
has been problems with this Boolean algorithm in the past with homopolymer errors in the
non-coding regions [8]. In a recent study this consistent error was offset with multiple probe
ligation amplification. With this probe, there were more accurate and consistent reads in
the homopolymer regions, one of the reasons this region is important is because repeated
base pairs can be indicative of cancers. By being able to find an accurate reading of the
specific repeated areas, there will be a heightened ability to create a specific biomarker for
future gene panels [8] .
6

Chapter 2
Bayesian Statistics
The traditional view of probabilistic or random processes defines the probability of a possible outcome of an experiment as the ratio between number of favorable outcomes and the
total number of trials. The standard example is rolling a die. This is sometimes called a
”frequentist” interpretation.
However, we often assign probabilities to things that are not the outcome of some infinitely repeatable experiment, link flipping a coin. One generic example is the probability
that the presence of a symptom indicates a specific illness. Does a person who has a cough
have COVID? Suppose B represent ”patient X has a cold symptoms” and A represent ”patient X has COVID”. We know the probability of a cough with COVID P (B|A) (conditional
probability). This leads to the question of how to properly assess the probability of a patient
who presents with a cough actually has COVID, given that (1) one can have COVID while
being asymptomatic and (2) a cough can be cause by a multitude of other conditions.

2.1

Bayes’ Theorem

One possible reasoning is as follows. Denote the probability that a person has COVID and
also has cold symptoms, or the joint probability P (A ∩ B). This can be written in term of
the absolute and conditional probabilities, as the absolute probability of A (that a person in
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the general population has COVID) multiplied by the conditional probability P (B|A) (that
a person with COVID has cold like symptoms):
P (A ∩ B) = P (A)P (B|A)

(2.1)

However, interchanging A and B, we obtain a different expression for the same joint probability (A ∩ B = B ∩ A therefore P (A ∩ B) = P (B ∩ A)), involving the absolute probability
P (B) and the conditional P (A|B).
P (B ∩ A) = P (B)P (A|B) ⇒ P (A)P (B|A) = P (B)P (A|B)

(2.2)

By dividing the two sides by P (B) (assuming it is nonzero), we obtain
Theorem 1. P (A|B) =

P (A)P (B|A)
; P (B) 6= 0 [9]
P (B)

One straightforward application is to a patient who actually has cold symptoms. In this
case P (B) = 1, thus the probability that the patient has COVID is P (A|B) = P (B|A)P (A).

2.2

Continuous Bayes’

In many cases, there is not one single prior, but a continuous range of various priors. For
instance, to drive 60 Miles on the freeway, it may take between 45 and 70 Minutes. Thus,
a probability density function (PDF) is necessary. A PDF can be thought of as a
continuous function that is created from a histogram. One of the most well known examples
is a Gaussian (or Normal) distribution.
Definition 2.2.1 (Probability Density Function). For some some continuous random variable x, for some non-zero function, f (x), the following are satisfied:
1. f (x) is positive everywhere in the defined interval. For sake of generality say:
f (x) > 0; ∀ x ∈ (−∞, ∞).
R∞
2. The area under the curve of f (x) is 1. Hence: −∞ f (x)dx = 1. The probability can
be written as: if f (x) is the PDF of x then the probability that x occurs within the fixed
8

interval of continuous events [a, b] is given by the following:
Z
P (x ∈ [a, b]) =

b

f (x)dx.[9]
a

With respect to Bayesian statistics. This PDF can be used as the prior distribution
discussed in the previous section. Maintaining similar notation to the previous section. Let
A be the continuously scaled parameter and let x be the observed sample data. Let A
be some continuous scaled parameter. We cannot observe A directly, but we can measure
another quantity x. We now that x depends on A; denote by f (x|A) the conditional PDF
of x. Furthermore, let f (x|A) be the likelihood function for some continuous A at a fixed
x. Lastly, let the posterior distribution be represented as ρ(A|x). It follows from Bayes’
Theorem (Theorem 1) that:
Z
f (x|A)ρ(A)
ρ(A|x) =
, Such that: fX (x) =
ρ(A)f (x|A)dA
(2.3)
fX (x)
A
As the posterior is proportionate to the likelihood multiplied by the prior, the past equation
be written as : ρ(A|x) ∝ f (x|A)ρ(A).
A related function that is also prevalent used in continuous Bayes’ is the cumulative
distribution function.
Definition 2.2.2 (Cumulative Distribution Function). A cumulative distribution function
(CDF) of a continuous distribution is defined as follows. Suppose X has a continuous distribution such that f (x) represents its PDF. Let F (x) represent the CDF that is continuous
for every F such that
Z
x

F (x) =

f (t)dt

[9].

−∞

From that definition we can derive another definition of the probability density function
such that f (x) = dFdx(x) . That is, the probability density function is the derivative of the
continuous density function.

9

2.3
2.3.1

Alternative discussion of the quality score
Continuous Bayes

Going back to Bayes’ Theorem (2.2):
P (A ∩ B) = P (A|B)P (B) = P (B|A)P (A) ⇒ P (A|B) =

P (B|A)P (A)
,
P (B)

(2.4)

we should point out that the second equality is the basis of a widely used approach to
estimating probabilities (or distributions of parameters) that are not directly accessible.
In Bayes’ theorem as stated above, A and B are statements that refer to an underlying
random process or variable. We previously mentioned the example of a diagnosis (A = ”the
patient has COVID”) based on the presence of a symptom (B = ”the patient has cold-like
symptoms”). The directly available observation, the symptom, is used to re-estimate the
probability of the more obscure condition, which may cause the symptoms. The general
probability P (A), called the prior, reflects some general knowledge about the prevalence of
the condition; this is important when multiple diagnoses are possible. If COVID is exceedingly rare, it is more likely that the cold-like symptoms are caused by the common cold, i.e.
we must also evaluate A0 = ”the patient has a cold”. The resulting P (A0 |B) will likely be
higher due to a higher prior P (A0 ).
Putting the entire reasoning together, we used our insight into the probability of observing
cold symptoms in people with COVID, P (B|A), or in people with the common cold, P (B|A0 ),
as well as our prior knowledge of the prevalence of COVID, respectively the common cold in
the general population, P (A) and P (A0 ), to come up with estimates for the probability that
our cold symptom patient has COVID or just a cold.
P (A|B) =

P (B|A0 )P (A0 )
P (B|A)P (A)
; P (A0 |B) =
.
P (B)
P (B)

(2.5)

This result can be used to compare the likelihoods of one or another diagnosis. Notice that
the probabilities are not guaranteed to add up to 1. Even if we know for sure that A and
A0 are mutually exclusive (which would guarantee that the sum does not exceed 1), there
could be any number of other conditions A00 , A000 , · · · that also cause the symptoms B, which
10

would account for the difference 1 − (P (A|B) + P (A0 |B)). The term ”likelihood” is often
used to describe quantities like the numerators in (2.5) or even the conditional probabilities
themselves. They are proportional to probabilities associated with random outcomes (does
my patient have COVID or a cold?) but they are not proper probabilities in that they are
not normalized.
The term ”Bayesian” refers to the practice of using empirical data to ”refine” what was
previously known about a probabilistic feature – which may be as simple as a statement
that may or may not be true, or the PDF of a set of parameters. It is useful to go through
an illustrative example of the Bayesian approach in a continuous setting. In one model of
disease propagation, the number of new cases per day, also called the incidence I, is a random
variable that follows a Poisson distribution
P (I) = q(I; Γ) =

ΓI −Γ
e
, I = 0, 1, 2, · · ·
I!

(2.6)

This formula provides the probability that there will be exactly I cases. The quantity Γ is
called the rate. In a common model of disease propagation, the rate is the product of the
infection potential Λ which is calculated from the number of past cases in the community,
and the reproduction number R. The reproduction number reflects the rate at which the
disease is spreading right now but is actually defined as the number of secondary cases that
result over time from one primary infection. Basically, it is not directly measurable, but
it is important in predicting the near term evolution of the outbreak. R is considered a
continuous random variable that follows a gamma distribution:
f (R) = CRa e−bR .

(2.7)

The parameters a, b of the PDF of R are estimated using a Bayesian approach as follows.
Assume we know the prior values aprior , bprior that applied before today.
The daily incidence is still a random variable, and the Poisson distribution (2.6) with Γ = RΛ
gives the probability of I cases conditional on the specific value of R, i.e. P (I|R). Then,
the joint probability (probability density for R) that today the incidence is I ∗ and the
reproduction number is R∗ is:
P (I|R)ρ(R) = q(I; RΛ)f (R; aprior , bprior ) =
11

(ΛR)I −ΛR
e
CRa e−bR
I!

(2.8)

By Bayes’s Theorem, this equals ρ(R|I)P (I) where ρ(R|I) is the PDF of R conditioned on
the incidence taking the specific value I and P (I) is the independent probability of the same.
So we can write
CΛI
ρ(R|I) =
· Raprior +I e(bprior +Λ)R
(2.9)
P (I)I!
Notice that this is proportional to a gamma distribution for R, with parameters
aposterior = aprior + I , bposterior = bprior + Λ .

(2.10)

But is it really a PDF? Not yet, for the same reason the likelihoods in (2.5) were not proper
probabilities. It is a likelihood function, which can be converted into a PDF. Once we know
the actual value of the incidence today, we have P (I) = 1. If that sounds suspicious, think
about the example with COVID vs. common cold. The actual value of P (I) doesn’t actually
matter. It does not depend on R. Actually, nothing else in that prefactor does. We can
convert (2.9) into a proper PDF, similar to (2.7); the resulting constant is
Z ∞
0
1/C =
Raprior +I e(bprior +Λ)R dR .
(2.11)
0

In summary, assuming a prior Gamma distribution for R, we can use the knowledge of the
actual incidence I and the infection potential Λ on the same day, to estimate the parameters
of the posterior distribution of R; this is an improvement on our prior knowledge, in that is
includes information from the current day.

2.3.2

Quality scores

The reasoning behind the quality scores used in base calling is somewhat similar to the
Bayesian approach discussed above. As I described in the previous chapters, a ”read” of a
specific position in the genome consists of a set of four intensity readouts from the chip that
refer to that location and correspond to the four bases (A, T, C, or G); this information is
then used to infer the identity of the base at that location, referred to as making a ”base
call”.
The intensity values may be affected by multiple sources of uncertainty, and the configuration of these values is correlated with the reliability of the resulting inference. A key idea
12

in Next Generation Sequencing methods is to use lower quality reads instead of discarding
them. If our case, this is facilitated by the fact that there are multiple reads made for each
base location. These reads would ideally point to the same ”call” (one of ATCG); the lower
the quality of the process, the higher the chance that different reads of the same location do
not match. The purpose of our base calling strategy is to combine multiple reads to come
up with the call that is most likely to be correct. One common approach is to assign a
quantitative quality score to each individual read, and use that to make a final call.
The general approach relies on deriving quality parameters for individual reads, such as: the
maximum intensity Imax maximum difference Imax − Imin and so on. Each individual read is
then characterized by a set of parameters p(1) , p(2) , · · · p(m) , and may be seen as a vector in
the space of parameter values. The key feature is that (1) parameter values are correlated
with higher quality reads but (2) the ordering is not unambiguous, in that two reads may
be sorted differently under two different parameters.
(1)

(2)

(m)

In the original approach [10], parameters are used to define cutoffs pcut , pcut , · · · pcut , and
reads below any cutoff are discarded. Assuming we have a way of counting errant and
correct reads, the overall quality of the cutoff strategy is then characterized by an error rate
(1)

(1)
(2)
e(pcut , pcut , · · · )

(1)

=

(2)

1.0 + err(pcut , pcut , · · · )
(1)

(2)

(1)

(2)

1.0 + err(pcut , pcut , · · · ) + corr(pcut , pcut , · · · )

(2)

(1)

,

(2.12)

(2)

where corr(pcut , pcut , · · · ) is the number of correct reads and err(pcut , pcut , · · · ) is the number
of incorrect
n reads that areoleft in place by the configuration of cutoffs. The cutoff strategy
(1)
(2)
(m)
~
Pcut = pcut , pcut , · · · pcut that minimizes (2.12) is optimal. The related Phred score is
defined as
phred(P~cut ) = −10 · log10 (e(P~cut )) .
(2.13)

2.3.3

One parameter quality score

Before addressing the problem of multiple parameters, focus on building a quality score
based on a single parameter. In our approach, the quality score must be assigned to each
individual read, based on the value of its quality parameter[s]. We do this based on a set
of reads of the genome of interest, that were obtained using the same physical process, and
13

were compared to a known reference. Thus we have access to a large number of reads, which
are known to be correct or incorrect, and whose parameter values are known.
Focus on a single parameter x which is positively correlated with the quality or reliability
of a read. In other words, read 1 with score x1 is more reliable than read 2 with score x2 , if
x1 > x2 . We want to construct a quality or credibility score function q(x) that increases from
0 to 1 over the range of possible values of x. Consider a histogram of correct and incorrect
calls as a function of the parameter x. This would result in two different density functions
ρc (x) (correct calls) and ρi (x) (incorrect calls) such that the number of correct calls in an
interval a ≤ x ≤ b is
Z b
Z b
ρc (x)dx ; i([a, b]) =
ρi (x)dx
(2.14)
c([a, b]) =
a

a

Counting the number of correct and wrong calls below x would not be a good way to define
an individual quality score function. If there is an interval where the density of correct calls
is lower than that of wrong calls, the error function (2.12) using the interval [−∞, x] would
actually decrease as the parameter value x increases. Instead, we use
q(x) =

Nc (≤ x)
,
1.0 + Ni (≥ x) + Nc (≤ x)

(2.15)

where
Nc (≤ x) ≡ c((−∞, x]) , Ni (≥ x) ≡ i([x, ∞)) .

(2.16)

The individual counts Nc (≤ x) and Ni (≥ x) may be interpreted as proportional to Bayesian
likelihoods, as described below. Denote by Nread the total number of reads, and by Nct =
Nc ((−∞, ∞)) and Nit = Ni ((−∞, ∞)) the total number of correct and incorrect reads,
respectively. Apply the Bayesian logic to statement A = ”the read is correct” and B = ”the
read has parameter ≥ x ”. The joint probability that a read is correct and has parameter
≥ x is approximated by the ratio of the number of such calls to the total number of reads.
P (A ∩ B) =

Nc (≤ x)
Nread

(2.17)

Write this as one side of the equality in Bayes’ Theorem,
P (A ∩ B) = P (B|A)P (A) =
14

Nc (≤ x) Nct
·
.
Nct
Nread

(2.18)

t

c
is the ”prior” – the probability that a read is correct, if we know nothing
Here, Pc = NNread
about its quality parameter x; the ratio NcN(≤x)
is the conditional that a correct read has
t
c
parameter value ≤ x. The other side of Bayes’ Theorem would be P (A|B)P (B) where
P (A|B) is the probability that a read with parameter ≤ x is correct and P (B) is the overall
probability that a read has parameter ≤ x. Similar to the examples above, when we apply
this to specific read with parameter equal to x, we take P (B) = 1 since the statement is true.
Thus, the right hand side of (2.17) gives the likelihood that a read with quality parameter
x is correct. This is actually a conservative estimate, since the likelihood that a read with
parameter exactly equal to x is correct is higher or equal to the same likelihood applied to
calls with parameter ≤ x. In summary:

`(c|x) ≥ `∗ (c|x) = `(c| ≤ x) =

Nc (≤ x)
Nread

(2.19)

We can make a similar argument regarding the likelihood that a read with parameter ≥ x is
incorrect. New we have A0 = ”the read is incorrect” and B 0 = ”the read has parameter ≥ x”.
The joint probability P (A0 ∩ B 0 ) equals the conditional P (B 0 |A0 ) multiplied by the ”prior”
probability that a read is incorrect P (A0 ) = Nit /Nread . The other side of Bayes’ Theorem
has the posterior P (A0 |B 0 ), the conditional probability that a call with parameter ≥ x is
incorrect multiplied by the probability that the parameter satisfies the condition ≥ x. We
again identify the right hand side with a likelihood, thus
`(i| ≥ x) =

Ni (≥ x)
Ni (≥ x) Nit
=
·
.
Nread
Nit
Nread

(2.20)

Finally, since the likelihood of a wrong call decreases as the parameter increases, the likelihood that a read with parameter equal to x is incorrect should be higher than the same
likelihood for reads with parameter ≥ x:
`(i|x) ≥ `∗ (i|x) = `(i| ≥ x) =

Ni (≥ x)
.
Nread

(2.21)

This likelihood decreases as the values of x increases, consistent with the idea that calls with
higher parameter values are more likely to be correct.
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Finally, the two likelihoods are combined into the quality score
`∗ (c|x)
q(x) =
=
1 + `∗ (c|x) + `∗ (i|x)

16

Nc (≤ x))
.
1.0 + Ni (≥ x) + Nc (≤ x)

(2.22)

Chapter 3
Related Work
Sequencing large quantities of DNA in the past has been either time consuming with Sanger
Sequencing or expensive with methods similar to Illumina’s Sequencing by Synthesis (SBS)
where the machines start around $100,000 [11]. SBS is considered the standard for most
NGS practices because of its high accuracy and its lack of need for priori data or a reference
genome. However, the cost of SBS remains high with the price averaging $1,000 per sample
[12].
Since SARS-CoV-2 is an ribonucleic acid (RNA) virus, there are further complications
because of the the natural instability of RNA. RNA is unstable because it is single stranded,
in contrast with DNA being double stranded, thus, it is more likely to degrade, because
ribose sugars have any extra hydroxyl in comparison to the deoxyribose sugar in DNA,
SARS-CoV-2, like other RNA viruses have high rates of mutation. Hence, the ability to
efficiently and inexpensively locate areas of high variation is advantageous. Because RNA
is single stranded instead of double stranded like DNA, there is an additional step in the
isolation process. The RNA is isolated similarly to DNA, but a reverse transcription step is
necessary to transcribe the strand into the typical nucleic acids associated with DNA [13].
With the additional step in the isolation process, sequencing becomes even more expensive and time consuming. Three of the alternative methods for whole genome sequencing
of viruses are: metagenomic sequencing, PCR amplification sequencing, target enrichment
sequencing. These methods are computationally expensive, highly labor intensive, and expensive respectively [14]. Furthermore, another aspect of an RNA virus is that they mutate
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rapidly giving rise to numerous variants [13]. Hence, SARS-CoV-2 is no different. Hence
there is motivation to create a method that is of high quality but more cost effective [15].
The main way this method reduces costs is by using a method called re-sequencing. Resequencing is the utilization of a reference genome during the sequencing process to assist
with the identification of correct calls. The procedure uses the knowledge of the known
sequence to create unique primers for each locus in the sequence. These primers attach to
the surrounding bases like a zipper to properly determine each call. There is one locus left
in the center that is unconnected so that the confocol scanner can detect the wavelength
at that location. The main negative aspect of this method arises in areas of high variation.
There, the primers have difficulty binding to the correct section and the readings become less
reliable. For whole genome sequencing, such as the case in this project, it is used mainly to
detect mutations, whether point-based, SNPs (single nucleotide polymorphism), or sections.
To have a high quality reference genome, the comparison sequence was generated using a
Illumina Sequencing by Synthesis instrument- MiSeq [15]. Thus, it is only necessary to pay
for the cost of sequencing by synthesis once, instead of every time a genome needs to be
processed. Therefore, prior to processing each sequence there is a template in which to
compare each read. This allows for a base-line understanding of what the sequence will be.
Thus, the processing energy is substantially decreased. Furthermore this method allows for
regions of variation in the genome to be quickly identified, since every base is being directly
compared to the reference genome. It is important to note that the SARS-CoV-2 genome
has a multitude of variations and what is being compared is just one specific sequence. With
Millions of cases, there are Millions of different possible sequences. Thus, it is necessary to
just pick just one for a proper comparison. This sequence can be thought of as a snap shot
of time. A similar method could be used to compare future clinical sequences to the delta,
omicron, or other variants.
The lab prepared the the samples by isolating the specific sample using a complementary
DNA (cDNA) strand . This allows for the desired strand of DNA to bind to the cDNA so
that the correct strand can be extracted from the clinical sample. This works by creating
hybridized tail on either end so that even if there are some small variations, the strand of
DNA binds to it’s compliment in the desired area of about 30,000 bases of the SARS-CoV-2
genome. The hybridized tail works as a marker so that the sequence and be split up into
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small segments and examined piece by piece and are dependent upon the previously known
sequence. After that the DNA is amplified using PCR with two two separate primers so that
there are a multitude of copies of the desired sequence. This allows for better examination
of the sequences in the future. After that, the samples are prepared for the Microchips to be
analyzed with the confocal scanner. This specific scanner works through the combination of
a specialized laser and a number of confocal lenses that change the direction of the laser and
focuses it towards the object of choice [16]. In this case, it is each node of the Microchip.
Each Microchip was scanned at four different intensity lengths of 0.5, 1, 4, and 8 seconds [15].
This results in reads that are dictated by various levels of saturation where the goal is to
eventually reach over-saturation such that in one of the read lengths, the optimal absorption
is recorded.
Now, the data is now able to be processed and optimized into the most correct strand.
The data available for analysis consists of sets of (four) intensity values IA , IT , IC , IG obtained
for individual loci on the genome. Each exposure time (typically 0.5, 1, 4, 8 seconds) provides
two readings of each locus, corresponding to the sense and anti-sense strands. Hence, there
are typically 8 reads per base for each sample and 32 reads per locus throughout the sample.
This can be visualized in the flow chart in figure 6 for the case used in the novel analysis.
The central task of the base calling algorithm is to identify the base (ATCG) at each locus,
based on the sets of four intensities reported in one (or multiple) reads.
Focusing on one read, consider one set of bases to describe the quality parameters. The
bases are in order of intensities such that Imax ≡ I3 ≥ I2 ≥ I1 ≥ I0 ≡ IM in . The maximum
intensity (I3 ) is compared The two main quality parameters examined in this method were
the maximum difference : Imax − IM in and the relative differential: (Imax − I2 )/(Imax − IM in ).
The density maps were generated and the cumulative density function is used to construct a
density function and assign a normalized quality score where 1 is the most likely to be correct
and 0 is the least likely to be correct. The logic follows similarly to section 2.3.3 but for two
parameters instead of three. The end result of the method performed on a two parameter
model was a 99.9% average accuracy for 95% for the genome of each clinical sample [15].
Furthermore, when compared to the Illumina output the coverage was comparable when
filtering out all of the Phred scores below 20 being on average just .73% different. Hence the
method created was comparable to the expensive standard of sequencing by synthesis using
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an Illumina machine.
However, when just two out of the three quality parameters being utilized in this method,
the natural next question leads to what improves when all three quality parameters are used
in the model. Hence, this project aims to determine the costs and benefits of using all of the
information provided by developing a three parameter model.
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Figure 2: One three-dimensional histogram of correct best calls used for creating the cumulative density function

Figure 3: One three-dimensional histogram of incorrect best calls used for creating the cumulative density function

Figure 4: A visual representation of the cumulative density function created with the two
histograms of correct and incorrect calls.

Figure 5
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Chapter 4
Methods
4.1

General Methods

Using the quality parameters outline in chapter 4.2, we have M d ≡ Imax − Imin , relative
Imax − I2
The max intensity call (Imax ) is then compared to the reference
differential: Rd =
Md
genome and each vector is further separated into correct and incorrect calls.
A statistical approach based in Bayesian statistics, the theory is found in chapter 2.3.3,
is used to deterMine with calls are correct or incorrect for each read in both the sense and
anti-sense strands. Each strand is calculated separately and then compared in the end, this
will be revisited once the main statistical methodology is explained.
The base associated with the maximum intensity of each loci is compared to the reference
genome and the clinical sample is separated into two array’s: correct and incorrect with
respect to the reference genome. From there, a three dimensional array is constructed using
the quality parameters: max difference, relative differential, and max intensity, which are
described in the previous section. As seen in figure 8, the calls tend to cluster towards the
higher end of the max intensity, relative differential corner and the max intensity seems to
follow in a linear cluster.
Suppose we take any location at random within the sequence, let x represent the prob-
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Nc
. The likelihood
Nt
0
of a call being correct increases with x. So, a call of x > x is more likely to be correct as
apposed to a call of just x. A continuous distribution of ρc (x) is used to determine the local
density (posterior) of some correct call x. This leads to a likelihood score of:
ability a call is correct (the prior), represented by the fraction: Pc ≈

Z

∞

lc (x) = Pc
x

Nc
ρc (x )dx =
Nt
0

0

Z
x

∞

ρc (x0 )dx0 =

Nc (x0 ≤ x)
.
Nt

(4.1)

This likelihood score can be applied similarly for the likelihood a call is incorrect by
creating a score that decreases as the value of x increases. Resulting in:
Z
Z x
Ni (x0 ≥ x)
Ni x
0
0
0
0
ρi (x )dx =
.
(4.2)
ρi (x )dx =
li (x) = Pi
Nt −∞
Nt
−∞
Both the likelihood correct and the likelihood incorrect are combined into the following
equation that was previously defined in 2.3.3
lc
q(x) =
=
1 + lc + li
1+

Nc (x0 ≤x)
Nt
0
Nc (x0 ≤x)
+ Ni (xNt≥x)
Nt

Nc (x0 ≤ x)
=
.
1 + Nc (x0 ≤ x) + Ni (x0 ≥ x)

(4.3)

This concept can be applied to the quality parameters: (Md,Rd,Mi) resulting in a score
on the interval [0, 1]. Applying those parameters, we arrive at:
lc (M d, Rd, M i) ≡ Nc (M d0 ≤ M d, Rd0 ≤ Rd, M i0 ≤ M i), and li (M d, Rd, M i) ≡
Ni (M d0 ≥ M d, Rd0 ≥ Rd, M i0 ≥ M i).

Allow some x ∈ M d, y ∈ Rd, z ∈ M i such that (x, y, z) = (M d, Rd, M i). Before
Nc
.
knowing their quality parameters, the probability that a call is correct is approximately
Nt
Furthermore, we can make the assumption that any call with (x, y, z) quality parameters
are more likely to be correct then any call with lower quality parameters such that x0 ≤ x,
y 0 ≤ y, and z 0 ≤ z. By letting ρc (x, y, z) represent the cumulative density for correct calls
in three-dimensions. If a read is correct, the probability that its quality parameters are all
below (x, y, z) is:
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0

0

Z

0

x

Z

y

Z

z

ρc (x0 , y 0 , z 0 )

P (x ≤ x, y ≤ y, z ≤ z| for a correct call) =
−∞

−∞

−∞

(4.4)

Nc (x0 ≤ x, y 0 ≤ y, z 0 ≤ z)
≈
.
Nt

M i)
Hence, lc (M d, NRd,
is the approximate probability that a call is correct as as quality
t
values that are worse than or equal to (M d, Rd, M i). This method assumes that a call is
correct based on its ability to match the reference genome and have M d0 ≤ M d, Rd0 ≤
Rd, M i0 ≤ M i.

Furthermore,
0

0

Z

0

∞

Z

∞

Z

P (x ≥ x, y ≥ y, z ≥ z| for an incorrect call) =
x

y

∞

ρi (x0 , y 0 , z 0 )

z

(4.5)

Ni (x0 ≥ x, y 0 ≥ y, z 0 ≥ z)
.
≈
Nt
li (M d, Rd, M i)
Nt

predicts that a score is wrong such that any given point as a better or equal
value to (M d, Rd, M i).
Applying these results from 4.4 and 4.5 to 4.3, we arrive at:
lc
q(x, y, z) =
=
1 + lc + li
1+
=

1+

Nc (x0 ≤x,y 0 ≤y,z 0 ≤z)
Nt
0
0
0
Nc (x0 ≤x,y 0 ≤y,z 0 ≤z)
+ Ni (x ≥x,yNt≥y,z ≥z)
Nt
Nc (x0 ≤ x, y 0 ≤ y, z 0 ≤ z)
Nc (x0 ≤ x, y 0 ≤ y, z 0 ≤ z)) + Ni (x0 ≥ x, y 0

(4.6)
≥ y, z 0 ≥ z)

.

From q(x, y, z), it can be seen that as q approaches 1, the more probable the call is
correct. Similarly as q approaches 0 the more probable the call is incorrect. From those
quality scores, a Phred score is calculated such that, phred = −10 log10(1 − q) where q is
the quality score q(x, y, z).
This method performed on both the sense and anti-sense strands and the quality scores
are compared at matching loci to create a resulting vector of the ”best reads” where the
highest value quality score is chosen. From that vector, the call strand is finalized and
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extracted as both an excel file and a FASFA file, used for further analysis in the partnering
wet lab.

4.2

Implementation of Methods

The intensity scores along with the reference genome from the wet lab are shared through
a JSON file. Those read and then extrapolated in MATLAB to be further analyzed. Each
clinical sample had at least one sense and one anti-sense reading. Thus, for each intensity
reading there are eight readings, four sense and four anti-sense, for each file which each file
is denoted by the clinical sample identifier and by the length the sample was read in the
confocal scanner (i.e. 0.5, 1, 4 seconds). The sense and anti-sense strands are split up into
two respective arrays and organized from maximum intensity value to minimum intensity
value (I3 ≥ I2 ≥ I1 ≥ I0 ). Furthermore, while also saving the original locations denoting the
base as numerical values in a respectively sorted array. From the array of intensity values the
following quality parameters are generated: maximum intensity as I3 , maximum difference
as I3 − I0 , and relative differential as (I3 − I2 )/(I3 − I0 ).
From there, the base associated with the maximum intensity is compared to the reference
genome and is further separated into correct and incorrect call arrays. The three quality
parameters are used to construct a three-dimensional CDF for both the correct and incorrect
arrays respectively. Each CDF is used to determine the likelihood a call is correct or incorrect
based in Bayes theory as described in section 4.1. This combination is used to construct a
normalized quality score from zero to one where zero is the least probable to be correct
and one is the most probable to be correct. The score is used to also calculate the Phred
score, the standard quality score in genomics, such that phred = −10 log10(1 − q) where q is
the previously calculated quality score (eq. 4.6). The quality scores between the sense and
anti-sense strands are compared at each loci and the base associated with the highest quality
score is chosen and stored in a vector. Thus, the resulting strand is the best call from the
clinical sample at a designated read length. The strand is exported into a FASTA file, the
standard text format for genetic sequences represented by the associated nucleotide’s first
letter, for use in the wet lab.
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This process is repeated for each sample at every read length. Once the process is
completed, it is necessary to find the best call by comparing the various read lengths for
each clinical sample. The quality scores from each length’s designated sequence of the best
reads from sense and anti-sense strands are compared. This results in a read sequence of the
best quality scores and takes the base associated with the best quality score of of all of the
samples and stores it in one single vector. Thus, the sequence is as correct as possible with
the given information. The process is repeated for every clinical sample and then end is one
sequence for each sample. The logic can be visualized in figure 6.
Once all of the samples have been thoroughly processed it is necessary to see if it is
possible to further optimize the sequences. The standard for a low quality Phred score
is any score below 20. Thus, the final sequence is filtered by removing the calls with an
associated low Phred score. As well, some intensity reads were unusually low, hence, a
similar process was repeated for all intensity reads below 200. The process was repeated
for a third time using both filters. All calls filtered out are labeled as non-calls, since their
results are not reliable.
Lastly, the resulting sequences, with and without filters, are compared to the reference
sequence. The result of the comparison determines how many calls are correct or incorrect
in comparison to the reference sequence. This does not necessarily mean that a call labeled
”incorrect” is actually the wrong read, but rather incorrect as different from the reference
sequence, which is the nature of re-sequencing. The data is stored for future analyses and the
sequence has been generated. From the generated sequences, the accuracy (Nc /(Nc + Ni ))
and coverage ((Nc + Ni )/Nt ) are calculated and compared between the two parameter and
three parameter models for the same sequence and a student’s t-test is used to calculate
statistical significance.
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Figure 6: This flow chart represents the number of reads per locus in the given genome for the
case processed in 4.2
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Figure 7: A close up diagram of the mechanisms that occurs when assigning a quality score to
each locus.

Figure 8: A scatter plot representation of the three-parameter cumulative density functions for
both correct (blue dot) and incorrect (red dot) calls.
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Chapter 5
Results
The main way to quantify these results is by examining how many calls are correct or
incorrect with respect to the reference genome. The three filters used were: Q20 (Phred
scores below 20 removed), Low intercity (Maximum Intensities below 200 removed), and both
Q20 and Low intensity. Quality of the samples were analysed by examining the accuracy
and coverage of the genome. Where the coverage is the percentage of the genome that has
a credible read for the specific filter. The coverage ranges from 56.96% to 98.65% with
a mean of 87.65% for two parameters and 89.27% for three parameters. However, when
performing a student’s t-test, the p-value ranges from 0.41-0.44 for the comparison between
2 parameters and 3 parameters within each respective group. Thus, there is no significant
difference between two and three parameters. The accuracy is calculated by the number of
correct calls divided by the number of calls total (i.e. no noncalls in the denominator). The
the accuracy ranges from 98.28% to 99.92% with a mean of 99.57% for two parameters and
99.59% for three parameters. Again when a student’s t-test was performed an insignificant
p-value ranging from 0.43-0.50. Thus, there is no significant difference between the results
from two and three parameters. The results for each filter can be found in figure 12.
The results for the calculated Phred scores for each Loci an be seen in figure 16. In the
two subfigures, 13, 14 the blue dots represent the correct calls and the red exes represent the
incorrect calls with respect to the bases. There is a noticeable cutoff point around Phred=20.
Furthermore, it is clear that the majority of the incorrect calls are found in the Phred scores
lower then 20 and the correct calls are mostly found in Phred scores above 20. However
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there is some overlap which is why a method similar to what is described in the paper is
necessary. The last subfigure, figure 15, shows the overlapping values of Phred scores for
each filter. As, visible and consistent with the insignificant p-values listed above, all Phred
scores seem to be nearly the same at each loci.
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Figure 9

Figure 10

Figure 11
Figure 12: ”Noncalls” refers to the number of base positions that were not called (or removed)
because they have a Phred score lower than 20 (figure 9) or a maximum intensity below 200
(figure 10). “Accuracy” is the number of correct calls divided by the number of total bases called.
“Coverage” the percentage of bases we have calls for ((correct calls+incorrect calls)/number of
bases)
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Figure 13: Two-parameter Phred scores in sample order of S20, S21, S22, S27 from top to
bottom.

Figure 14: Three-parameter Phred scores in in sample order of S20, S21, S22, S27 from top to
bottom.

Figure 15
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Figure 16: The above figures are two different representations of Phred scores in a segment of
the genome. In figure 13, and 14 represent the correct (blue dot) and incorrect (red ex) calls as
their Phred scores. Figure 15 represents the corresponding phred scores to all samples in both
two (2d) and three (3d) parameters

.

Chapter 6
Discussion
As Next Generation Sequencing is becoming more prevalent in common clinical use, there
is a move to constantly improve the accuracy and decrease the cost. Throughout this thesis
we explored the use of a re-sequencing technique based in Bayes’ Theory. It was previously
demonstrated that a two parameter quality score showed promising results [15]. However
from the quality parameters calculated to complete that method, one parameter was neglected in the construction of the likelihood function – maximum intensity. Thus, the question arose whether there is a benefit to adding maximum intensity to the likelihood function
in order to utilize all available information. Hence, this thesis.
The purpose of this research was to determine if there was a benefit to adding a third
parameter to the likelihood function to calculate the validity of each base call. It was found
that there is no significant difference between two and three parameters with respect to
coverage or accuracy in each filter. Thus, there is no demonstrated benefit in adding a third
parameter. Another impact of adding a third parameter is the processing time. It is always
beneficial to get the most information in the least amount of time. Because of the nature of
the program, by adding a third dimension, the run time quadrupled in time. Hence, there is
a clear detriment to adding a third parameter. Therefore, though it is important to explore
the implications of adding a third parameter to the likelihood function, it does not contribute
significantly to the information gathered and has a much longer processing time. Thus, I
would conclude that proceeding with just two parameters is sufficient.
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Appendix A
Supplementary Table of Symbols and
WoRds
I

Intensity

I3 ≡ Imax

Maximum Intensity Reading

I2 and I3

Second and third largest Intensity Reading

I0 ≡ IM in

Third Largest Intensity Reading

IA

Intensity Reading relating to Adenine

IC

Intensity Reading relating to Cytosine

IG

Intensity Reading relating to Guanine

IT

Intensity Reading relating to Thymine

Md

Max Difference = Imax − Imin

Rd

Relative Differential =

Mi

Max Intensity = Imax

Pc

Probability a call is correct

Pi

Probability a call is incorrect

Nc

Number of intensity reading calls correct

Ni

Number of intensity reading calls incorrect

Nt

Total Number of intensity readings

ρc

local density function for correct calls

ρi

local density function for incorrect calls

Imax −I2
Mi
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lc

Likelihood a call is Correct

li

Likelihood a call is Incorrect

Loci

Specific location in a genomic sequence

SBS

Sequencing By Synthesis

Base

Nucleic Acid or Nucleotide

Sense

The forward reading strand of DNA, read from 3’ to 5’

Anti-Sense

The reverse reading strand of DNA read from 5’ to 3’

PDF

Probability Density Function

CDF

Cumulative Density Function

cDNA

Complementary DNA
Table 1: Reference Table for Abbreviations and common terms
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